跳至主要内容
临床试验/NCT04178343
NCT04178343已完成不适用

Tomotherapy for Leptomeningeal Metastases: a Single Arm, Single Center, Phase II Trial

Chinese Academy of Medical Sciences1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
103
试验地点
1
主要终点
overall survival

研究概览

简要总结

This clinical trial was designed to investigate the efficiency and toxicity of tomotherapy for leptomeningeal metastases.

详细描述

This is a single-arm, single center, phase II trial to investigate the feasibility and toxicity of tomotherapy for leptomeningeal metastases, which are defined as leptomeningeal metastases with or without brain metatstases.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologic or cytologic diagnosis of primary tumor and conformed meningeal metastases by enhanced MRI; KPS ≥60,or KPS ≥40 and the limitation of motion is simply caused by brain tumor that is adjacent to the motor function areas; Age: 18-75 years old; Adequate organ function:WBC≥4.0x109/L Neu ≥ 1.5x109/L Hemoglobin ≥ 110 g/L Platelets ≥100 x109/L Total bilirubin ≤ 1.5x ULN AST and ALT ≤ 1.5x ULN BUN and Cr: within the normal range.

排除标准

  • Other clinically significant diseases (e.g.myocardial infarction within the past 6 months, severe arrhythmia); unable or unwilling to comply with the study protocol; patients who are anticipated in other clinical trials of meningeal metastases; pregnant patients or female patients whose HCG is positive; unsuitable to participate in study, that in the opinion of the treating physician.

结局指标

主要结局

overall survival

时间窗: up to 2 years

the time from radiation to death

次要结局

  • progress free survival rate(up to 1 year)
  • local control(up to 1 year)
  • adverse event(up to 2 years)
  • intracranial progress free survival(up to 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianping Xiao

Dr

Chinese Academy of Medical Sciences

研究点 (1)

Loading locations...

相似试验

Tomotherapy for Leptomeningeal Metastases | 临床试验